J&J | JNJ - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
AbbVie USD -5.94B 721M 2026-06
Abbott USD 52.06B 69M 2026-03
Amgen USD 11.69B 2.5B 2026-06
AstraZeneca USD 50.3B 2.96B 2026-06
Baxter International USD 6.21B 163M 2026-06
Bayer EUR 29.71B 863M 2026-06
Becton, Dickinson and Co. USD 24.42B 283M 2026-06
Biogen USD 18.85B 196.3M 2026-06
Boston Scientific USD 24.93B 934M 2026-06
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
CONMED USD 1.04B 23.72M 2026-06
Cooper Companies USD 8.33B 89.1M 2026-06
Dexcom USD 2.62B 335.5M 2026-06
Edwards Lifesciences USD 10.62B 290.5M 2026-06
Eli Lilly USD 33.88B 2.68B 2026-06
Gilead Sciences USD 11.74B 11.77B 2026-06
GlaxoSmithKline GBP 17.64B 223M 2026-06
Globus Medical USD 4.77B 36.29M 2026-06
Insulet USD 1.42B 119.6M 2026-06
Integra LifeSciences USD 1.04B 971K 2026-06
Intuitive Surgical USD 18.17B 693.9M 2026-06
J&J USD 84.97B 3.78B 2026-06
Medtronic USD 50.23B 160M 2026-06
Merck USD 41.93B 3.94B 2026-06
Merit Medical Systems USD 1.68B 53.08M 2026-06
Novartis USD 41.95B 3.02B 2026-06
Pfizer USD 85.19B 4.91B 2026-06
Regeneron Pharmaceuticals USD 31.71B 287.8M 2026-06
Roche Holding CHF 32.69B 1.11B 2026-06
Sanofi EUR 69.57B 3.24B 2026-06
Stryker USD 22.98B 559M 2026-03
Tandem Diabetes Care USD 130.39M 2.02M 2026-06
Teva Pharmaceutical Industries USD 7.75B 475M 2026-06
Vertex Pharmaceuticals USD 20.25B 886M 2026-06
Zimmer Biomet Holdings USD 12.63B 49.1M 2026-06
Zoetis USD 3.15B 85M 2026-06